abrdn Investment Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
abrdn Investment Management's BSX Position: Q2 2017 in Review
abrdn Investment Management reduced its Boston Scientific (BSX) stake by 23% in Q2 2017, selling an estimated $114M and leaving 14,537,918 shares worth $403M. The position accounts for 1.36% of the portfolio, ranked #20.
abrdn Investment Management first reported a position in BSX in Q2 2013 and has held it in 17 quarters since. The position peaked at $469M in Q1 2017. 558 funds tracked by Wall St. Rank hold BSX as of Q2 2017.
- abrdn Investment Management held 14,537,918 shares of Boston Scientific worth $403M as of Q2 2017.
- abrdn Investment Management sold 4,305,890 Boston Scientific shares in Q2 2017, an estimated $114M.
- Boston Scientific made up 1.36% of abrdn Investment Management's portfolio in Q2 2017, its #20 holding.
- abrdn Investment Management first reported a position in Boston Scientific in Q2 2013 and has held it in 17 quarters since.
- abrdn Investment Management's Boston Scientific position peaked at $469M in Q1 2017.
- 558 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2017.
Based on abrdn Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.